Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

210 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
X gene and precore region mutations in the hepatitis B virus genome in persons positive for antibody to hepatitis B e antigen: comparison between asymptomatic "healthy" carriers and patients with severe chronic active hepatitis.
Fukuda R, Nguyen XT, Ishimura N, Ishihara S, Chowdhury A, Kohge N, Akagi S, Watanabe M, Fukumoto S. Fukuda R, et al. Among authors: ishimura n. J Infect Dis. 1995 Nov;172(5):1191-7. doi: 10.1093/infdis/172.5.1191. J Infect Dis. 1995. PMID: 7594653
Role of hepatitis B virus in non-B, non-C chronic liver disease: in vitro proliferation and interferon-gamma production of peripheral blood mononuclear cells in response to hepatitis B core antigen and its relation to hepatitis activity.
Niigaki M, Fukuda R, Hamamoto S, Ishimura N, Ishihara S, Akagi S, Watanabe M, Kinoshita Y. Niigaki M, et al. Among authors: ishimura n. Am J Gastroenterol. 2000 Jan;95(1):239-47. doi: 10.1111/j.1572-0241.2000.01650.x. Am J Gastroenterol. 2000. PMID: 10638591
Co-infection by serologically-silent hepatitis B virus may contribute to poor interferon response in patients with chronic hepatitis C by down-regulation of type-I interferon receptor gene expression in the liver.
Fukuda R, Ishimura N, Hamamoto S, Moritani M, Uchida Y, Ishihara S, Akagi S, Watanabe M, Kinoshita Y. Fukuda R, et al. Among authors: ishimura n. J Med Virol. 2001 Mar;63(3):220-7. doi: 10.1002/1096-9071(200103)63:3<220::aid-jmv1004>3.0.co;2-3. J Med Virol. 2001. PMID: 11170061 Clinical Trial.
Strategic compartmentalization of Toll-like receptor 4 in the mouse gut.
Ortega-Cava CF, Ishihara S, Rumi MA, Kawashima K, Ishimura N, Kazumori H, Udagawa J, Kadowaki Y, Kinoshita Y. Ortega-Cava CF, et al. Among authors: ishimura n. J Immunol. 2003 Apr 15;170(8):3977-85. doi: 10.4049/jimmunol.170.8.3977. J Immunol. 2003. PMID: 12682225
210 results